Literature DB >> 15666573

Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy.

David B Arciniegas1, Kimberly L Frey, C Alan Anderson, Kristin M Brousseau, Susie N Harris.   

Abstract

Delayed post-hypoxic encephalopathy is an uncommon but potentially debilitating consequence of hypoxic-ischemic brain injury. This condition is characterized by delayed neurological deterioration days-to-weeks after an initial partial or complete recovery from hypoxic-ischemic brain injury. The course of recovery from this condition is highly variable, ranging from rapid and fatal progression over several weeks to delayed but occasionally complete recovery. There are no reports describing neurorehabilitative, including neuropharmacologic, interventions for persons with persistent neurological and/or neurobehavioural deficits following delayed post-hypoxic encephalopathy. This study describes the case of a 24-year old male who developed delayed post-hypoxic encephalopathy following an unintentional methadone and diazepam overdose and who demonstrated cognitive and neurobehavioural improvements during treatment with amantadine HCl hydrochloride in a single-case, open-label design. A brief review of the literature regarding this condition, its treatment and suggestions for further study are presented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15666573     DOI: 10.1080/02699050410001720130

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  14 in total

1.  The syndrome of delayed post-hypoxic leukoencephalopathy.

Authors:  David Shprecher; Lahar Mehta
Journal:  NeuroRehabilitation       Date:  2010       Impact factor: 2.138

Review 2.  Catatonia after cerebral hypoxia: do the usual treatments apply?

Authors:  Davin K Quinn; Christopher C Abbott
Journal:  Psychosomatics       Date:  2014-03-27       Impact factor: 2.386

3.  Reversible hypoxic brain injury: the penumbra conundrum of Grinker.

Authors:  Shiva Balan; Kartik Gupta; Parthiban Balasundaram; Ranveer Jadon
Journal:  BMJ Case Rep       Date:  2019-04-23

4.  Psycholinguistics of Aphasia Pharmacotherapy: Asking the Right Questions.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Abigail Oveis
Journal:  Aphasiology       Date:  2014-01-01       Impact factor: 2.773

5.  Amantadine for adynamic speech: possible benefit for aphasia?

Authors:  Anna M Barrett; Paul J Eslinger
Journal:  Am J Phys Med Rehabil       Date:  2007-08       Impact factor: 2.159

Review 6.  Drug therapy of post-stroke aphasia: a review of current evidence.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller; Guadalupe Dávila; Natalia García Casares; Antonio Gutiérrez
Journal:  Neuropsychol Rev       Date:  2011-08-16       Impact factor: 7.444

7.  Methadone-induced delayed posthypoxic encephalopathy: clinical, radiological, and pathological findings.

Authors:  Manoj Mittal; Yunxia Wang; Alan Reeves; Kathy Newell
Journal:  Case Rep Med       Date:  2010-12-09

8.  Delayed Post-Hypoxic Leukoencephalopathy Following Nitrite Poisoning: A Case Report and Review of the Literature.

Authors:  Yankun Chen; Qiumei Liu; Jian Wang; Hui Li; Yousheng Zhang; Lingling Sun; Jianli Liu
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

Review 9.  Delayed posthypoxic leukoencephalopathy: a case series and review of the literature.

Authors:  Carlos A Zamora; David Nauen; Robert Hynecek; Ahmet T Ilica; Izlem Izbudak; Haris I Sair; Sachin K Gujar; Jay J Pillai
Journal:  Brain Behav       Date:  2015-07-03       Impact factor: 2.708

Review 10.  Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.

Authors:  Erin L Winstanley; James J Mahoney; Felipe Castillo; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.